Insider · CIK 0001739515

Berger Dietmar

Reports to the SEC for 3 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001739515

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+533 sh	—	—	19,785
2026-09-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−533 sh	—	—	46,395
2026-09-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−263 sh	$144.81	−$38.1K	19,522
2026-06-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+533 sh	—	—	19,515
2026-06-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−533 sh	—	—	46,928
2026-06-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−263 sh	$121.48	−$31.9K	19,252
2026-03-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,133 sh	—	—	20,045
2026-03-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−1,063 sh	$148.56	−$158K	18,982
2026-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,133 sh	—	—	39,046
2026-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+8,415 sh	—	—	47,461
2026-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+31.5K sh	—	—	31,475
2026-02-27	GILDGILEAD SCIENCES, INC.A Award	Chief Medical Officer	AAward	+8,530 sh	—	—	17,912
2026-01-02	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.3K sh	—	—	16,326
2026-01-02	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−6,944 sh	$121.60	−$844K	9,382
2026-01-02	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.3K sh	—	—	41,179
2025-03-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+37.7K sh	—	—	37,710
2025-03-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+8,530 sh	—	—	57,505
2025-01-02	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+49K sh	—	—	48,975
2019-05-07	ATRAAtara Biotherapeutics, Inc.F Tax Payment	Global Head of R&D	FTax Payment	−4,322 sh	$33.46	−$145K	85,678
2019-03-26	ATRAAtara Biotherapeutics, Inc.A Award	Global Head of R&D	AAward	+15K sh	—	—	90,000
2019-02-06	ATRAAtara Biotherapeutics, Inc.A Award	Global Head of R&D	AAward	+25K sh	—	—	75,000
2019-02-06	ATRAAtara Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Global Head of R&D	AAward	+50K sh	—	—	50,000
2018-05-07	ATRAAtara Biotherapeutics, Inc.A Award	Global Head of R&D	AAward	+50K sh	—	—	50,000
2018-05-07	ATRAAtara Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Global Head of R&D	AAward	+85K sh	—	—	85,000

Recent filings

Accepted (ET)
Sep 114
Berger Dietmar0001739515-26-000011
SEC(opens sec.gov)
Jun 114
Berger Dietmar0001739515-26-000008
SEC(opens sec.gov)
Mar 124
Berger Dietmar0001739515-26-000006
SEC(opens sec.gov)
Mar 24
Berger Dietmar0001739515-26-000004
SEC(opens sec.gov)
Jan 54
Berger Dietmar0001739515-26-000002
SEC(opens sec.gov)
Mar 124
Berger Dietmar0001127602-25-009263
SEC(opens sec.gov)
Jan 34
Berger Dietmar0001127602-25-000548
SEC(opens sec.gov)
May 84
Berger Dietmar0001209191-19-028232
SEC(opens sec.gov)
Mar 274
Berger Dietmar0001209191-19-021442
SEC(opens sec.gov)

Companies

Address

333 LAKESIDE DR.

FOSTER CITY, CA, 94404